신경중재 기기 시장 규모 : 제품 유형별, 용도별, 최종 사용자별, 지역별 및 예측별

Global Neurointerventional Device Market Overview

The neurointerventional device market refers to the segment of the medical device industry focused on the production, distribution, and use of specialized devices designed to diagnose and treat disorders of the blood vessels in the brain and spinal cord through minimally invasive procedures. These devices include microcatheters, guidewires, embolization coils, stent retrievers, flow diversion devices, and aspiration systems that allow physicians to access complex neurovascular structures using catheter-based techniques. Neurointerventional devices are widely used in hospitals, specialized neurological centers, and advanced surgical facilities for the treatment of conditions such as ischemic stroke, brain aneurysms, and arteriovenous malformations.

Market growth is supported by the increasing prevalence of stroke and other neurovascular disorders, along with rising demand for minimally invasive treatment procedures. Improvements in neuroimaging technologies, expansion of specialized stroke centers, and advancements in catheter-based treatment techniques are also contributing to higher adoption of neurointerventional devices. As healthcare providers continue to focus on rapid diagnosis and effective treatment of neurological emergencies, the use of advanced neurointerventional technologies remains an important component of modern neurovascular care across global healthcare systems.

Market size -VMR Analyst Corridor Approach

A revenue convergence corridor is emerging across recent global assessments instead of relying on a single-point estimate. Market value is consolidating around USD 2.7 Billion in 2025, while long-term projections are extending toward USD 5.3 Billion by 2033, reflecting mid- to high-single-digit growth momentum. A CAGR of 8.8 % is being recorded over the forecast period (2027-2033), underscoring the market's structurally resilient growth trajectory

Global Neurointerventional Device Market Definition

The neurointerventional device market refers to the commercial ecosystem surrounding the production, distribution, and use of specialized medical devices designed to treat disorders affecting the blood vessels of the brain and spinal cord through minimally invasive procedures. These devices include products such as microcatheters, guidewires, embolization coils, stent retrievers, aspiration systems, and flow diversion devices that help physicians navigate complex neurovascular structures and perform targeted treatments. The market includes a wide range of neurointerventional devices used across hospitals, specialized neurological centers, and advanced surgical facilities for the treatment of conditions such as stroke, brain aneurysms, and arteriovenous malformations.

Market dynamics involve procurement by healthcare institutions such as hospitals, specialty neurological clinics, and advanced surgical centers that rely on neurointerventional devices for accurate diagnosis and minimally invasive treatment of neurovascular disorders. The supply chain includes medical device manufacturers, component suppliers, distributors, and healthcare equipment providers responsible for delivering these products to healthcare facilities. Distribution channels typically involve hospital procurement systems, medical device distributors, and specialized healthcare suppliers that ensure the continuous availability of neurointerventional devices for neurological treatment across global healthcare markets.

Global Neurointerventional Device Market Drivers

The market drivers for the neurointerventional device market can be influenced by various factors. These may include:

Rising Incidence of Neurovascular Disorders

The increasing prevalence of neurovascular disorders such as ischemic stroke, brain aneurysms, and arteriovenous malformations is driving demand for neurointerventional devices. These conditions often require rapid and minimally invasive treatment to restore blood flow and prevent neurological damage. Neurointerventional procedures such as thrombectomy, embolization, and aneurysm coiling rely on specialized devices including microcatheters, stents, and clot retrieval systems. As the number of neurovascular cases continues to rise globally, healthcare providers are increasing the adoption of advanced neurointerventional technologies.

Expansion of Healthcare Infrastructure and Specialized Neurological Centers

The expansion of healthcare infrastructure across many regions is supporting the growth of the neurointerventional device market. Governments and private healthcare organizations are investing in advanced hospitals, stroke care units, and specialized neurological treatment centers. These facilities require modern imaging systems and neurointerventional equipment to perform complex procedures. The increasing establishment of dedicated stroke centers and neurovascular treatment units is contributing to higher demand for neurointerventional devices.

Rising Prevalence of Chronic Diseases Linked to Stroke Risk

Chronic health conditions such as hypertension, diabetes, obesity, and cardiovascular disease are increasing the risk of stroke and other neurovascular complications. Patients affected by these conditions often require early diagnosis and timely interventional treatment to prevent severe neurological damage. Neurointerventional procedures offer targeted treatment options that help restore blood circulation in affected brain vessels. The growing burden of these chronic conditions is therefore supporting demand for neurointerventional treatment devices.

Growth of Minimally Invasive Treatment Approaches

The growing preference for minimally invasive procedures is creating opportunities in the neurointerventional device market. Compared with traditional open brain surgery, catheter-based neurointerventional techniques offer shorter recovery times, lower surgical risks, and reduced hospital stays. Hospitals and neurological centers are increasingly adopting these procedures for the treatment of complex brain conditions. Continuous improvements in catheter technology, imaging guidance systems, and device design are further supporting the expansion of minimally invasive neurovascular treatments.

Global Neurointerventional Device Market Restraints

Several factors act as restraints or challenges for the neurointerventional device market. These may include:

High Production and Technology Costs

The manufacturing of neurointerventional devices involves advanced materials, precision engineering, and highly controlled production processes. Devices such as microcatheters, guidewires, embolization coils, and stent retrievers require specialized materials and complex design structures to ensure accuracy and safety during delicate brain procedures. In addition, strict sterilization standards and detailed quality testing increase manufacturing expenses. These cost factors can influence product pricing and create challenges for smaller manufacturers entering the market.

Strict Regulatory and Approval Requirements

Neurointerventional devices must meet strict regulatory standards before being approved for clinical use. Regulatory authorities require extensive clinical testing, product validation, and detailed documentation to confirm safety and effectiveness. Obtaining approvals from different regulatory bodies across global markets can involve lengthy review processes and additional certification requirements. These regulatory procedures may increase operational costs and delay the introduction of new devices into the market.

Risk of Procedural Complications

Neurointerventional procedures involve treating delicate blood vessels in the brain, which carries a risk of complications if devices are not used correctly or if technical challenges occur during treatment. Possible risks include vessel damage, bleeding, or incomplete clot removal in stroke procedures. These concerns require highly trained medical professionals and advanced medical equipment to ensure successful treatment outcomes. The need for specialized expertise and careful procedural management can influence the adoption of neurointerventional devices in some healthcare settings.

Limited Access to Specialized Healthcare Facilities

The use of neurointerventional devices often requires advanced imaging systems, specialized treatment centers, and experienced neurointerventional specialists. Many developing regions still have limited access to such specialized healthcare infrastructure. As a result, patients in certain areas may not have timely access to neurointerventional treatments. This limited availability of specialized medical facilities and trained professionals can restrict market growth in some regions.

Global Neurointerventional Device Market Opportunities

The landscape of opportunities within the neurointerventional device market is driven by several growth-oriented factors and shifting global demands. These may include:

Increasing Incidence of Stroke and Neurovascular Disorders

The rising number of stroke cases and other neurovascular disorders is creating strong demand for neurointerventional devices. Conditions such as ischemic stroke, brain aneurysms, and arteriovenous malformations often require rapid medical intervention to restore blood flow in the brain. Neurointerventional procedures such as thrombectomy, embolization, and aneurysm coiling rely on specialized devices including microcatheters, guidewires, and stent retrievers. As healthcare systems focus on early diagnosis and rapid treatment of neurological emergencies, the demand for neurointerventional devices is expected to increase.

Growth of Ambulatory Surgical Centers and Specialized Neurological Care

The expansion of ambulatory surgical centers and specialized neurological treatment facilities is contributing to the demand for neurointerventional devices. Many minimally invasive neurovascular procedures can now be performed in advanced outpatient facilities equipped with imaging and catheter-based treatment systems. These centers provide faster treatment, reduced hospital stays, and improved patient convenience. The increasing preference for minimally invasive procedures is encouraging greater adoption of neurointerventional technologies in such healthcare environments.

Expansion of Advanced Neuroimaging and Diagnostic Capabilities

Advancements in medical imaging technologies are improving the detection and treatment planning of neurological disorders. High-resolution imaging systems such as CT angiography and MRI enable physicians to identify vascular blockages, aneurysms, and other abnormalities more accurately. Improved diagnostic capabilities allow healthcare professionals to perform targeted neurointerventional procedures using specialized devices. This progress in diagnostic imaging is supporting the broader use of neurointerventional treatment methods.

Technological Advancements in Neurointerventional Devices

Continuous improvements in medical device design are supporting the development of more precise and effective neurointerventional tools. Manufacturers are introducing advanced microcatheters, embolization coils, stent systems, and clot retrieval devices designed to improve treatment outcomes. These devices allow physicians to navigate complex brain vessels and perform procedures with greater accuracy and safety. Ongoing innovation in device technology is creating new opportunities for growth in the neurointerventional device market.

Global Neurointerventional Device Market Segmentation Analysis

The Global Neurointerventional Device Market is segmented based on Product Type, Application, End-User, and Geography.

Neurointerventional Device Market, By Product Type

Embolic Coils: The embolic coils segment accounts for a major share of the neurointerventional device market as these devices are widely used for the treatment of intracranial aneurysms and other vascular abnormalities in the brain. Embolic coils are inserted into aneurysms through minimally invasive procedures to promote blood clot formation and prevent rupture. Their effectiveness in reducing the risk of hemorrhagic stroke and improving patient outcomes has led to widespread adoption in neurovascular procedures. Increasing cases of brain aneurysms and growing preference for minimally invasive treatments are supporting steady demand for embolic coils.

Neurovascular Stents: The neurovascular stents segment is witnessing strong growth due to the rising use of stent-assisted procedures for treating complex aneurysms and intracranial artery stenosis. These stents help maintain proper blood flow in narrowed or weakened blood vessels within the brain. Neurovascular stents are often used in combination with embolic coils to support aneurysm treatment and prevent recurrence. Advancements in stent design, improved flexibility, and enhanced deliverability are encouraging wider adoption of these devices in neurointerventional procedures.

Neurothrombectomy Devices: The neurothrombectomy devices segment is gaining traction as healthcare providers increasingly adopt mechanical thrombectomy procedures for the treatment of acute ischemic stroke. These devices are designed to remove blood clots from blocked cerebral arteries, helping restore blood circulation to affected brain regions. Rapid intervention using neurothrombectomy devices can significantly improve patient recovery outcomes in stroke cases. The rising global burden of stroke and increasing availability of specialized stroke treatment centers are supporting the expansion of this segment.

Neurointerventional Device Market, By Application

Stroke: The stroke segment accounts for the largest share of the neurointerventional device market due to the increasing global prevalence of ischemic and hemorrhagic strokes. Neurointerventional devices such as thrombectomy devices, aspiration catheters, and stent retrievers are widely used to restore blood flow in blocked cerebral arteries during acute stroke treatment. Hospitals and specialized stroke centers increasingly rely on minimally invasive neurovascular procedures for rapid intervention and improved patient outcomes. Rising awareness regarding early stroke diagnosis, expanding stroke treatment centers, and improvements in endovascular technologies continue to support the growth of this segment.

Cerebral Aneurysm: The cerebral aneurysm segment is witnessing steady growth as neurointerventional devices are widely used to treat weakened or bulging blood vessels in the brain. Devices such as flow diverters, embolization coils, and intracranial stents are commonly used in minimally invasive procedures to prevent aneurysm rupture and reduce the risk of life-threatening complications. Increasing use of advanced imaging technologies and improved diagnostic capabilities is helping detect aneurysms at earlier stages. Growing preference for endovascular procedures over traditional open brain surgery is also contributing to the expansion of this segment.

Arteriovenous Malformations: The arteriovenous malformations segment is gaining traction as neurointerventional procedures are increasingly used to manage abnormal connections between arteries and veins in the brain. Treatment methods often involve embolization techniques using specialized catheters and embolic agents to block abnormal blood flow. Hospitals and neurological treatment centers are adopting these minimally invasive procedures to reduce complications associated with open surgical treatment. Rising awareness of neurovascular disorders, improving diagnostic technologies, and growing availability of specialized neurointerventional treatment centers are supporting demand for devices used in the treatment of arteriovenous malformations.

Neurointerventional Device Market, By End-User

Hospitals: The hospitals segment accounts for the largest share of the neurointerventional device market as hospitals handle a high volume of neurological emergencies and complex neurovascular procedures. These facilities are equipped with advanced imaging technologies and specialized neurointerventional units required for procedures such as thrombectomy, aneurysm coiling, and stent placement. The increasing incidence of stroke, brain aneurysms, and other neurovascular disorders continues to drive demand for neurointerventional devices in hospital settings. The presence of skilled neurosurgeons, interventional radiologists, and well-established neurological care infrastructure further supports the dominance of this segment.

Ambulatory Surgical Centers: The ambulatory surgical centers segment is witnessing gradual growth as minimally invasive neurovascular procedures become more common. These centers offer cost-effective treatment options and shorter patient recovery times compared with traditional hospital stays. Neurointerventional procedures that require limited hospitalization can increasingly be performed in well-equipped ambulatory facilities. The expansion of outpatient surgical services and improvements in imaging and catheter-based technologies are supporting the adoption of neurointerventional devices in these centers.

Specialty Clinics: The specialty clinics segment is gaining attention as dedicated neurological and neurovascular care centers expand in many regions. These clinics focus on diagnosis, follow-up care, and certain interventional procedures related to neurological disorders. Increasing awareness of early stroke treatment, improved diagnostic capabilities, and the growth of specialized neurology practices are contributing to rising demand for neurointerventional devices in specialty clinic settings. The availability of focused expertise and specialized patient care services also supports the growth of this segment.

Neurointerventional Device Market, By Geography

North America: North America holds a strong share of the neurointerventional device market due to the presence of advanced healthcare infrastructure and high healthcare spending. Hospitals and specialized neurological centers widely use neurointerventional devices for the treatment of conditions such as stroke, brain aneurysms, and arteriovenous malformations. The region also benefits from the presence of leading medical device manufacturers and well-established hospital networks. Increasing incidence of neurological disorders, rising adoption of minimally invasive procedures, and growing awareness regarding early stroke treatment are supporting market growth across the United States and Canada.

Asia Pacific: Asia Pacific is witnessing strong growth in the neurointerventional device market as healthcare infrastructure continues to expand across developing economies. Countries such as China, India, Japan, and South Korea are experiencing increasing cases of stroke and other neurovascular conditions, which is driving demand for advanced treatment devices. Government investments in healthcare systems, improving access to specialized neurological care, and growing patient populations are supporting market growth. The expansion of hospitals and specialized neurology centers is also contributing to rising adoption of neurointerventional procedures in the region.

Europe: Europe accounts for a considerable share of the neurointerventional device market due to well-developed healthcare systems and strong clinical expertise in neurological care. Hospitals and neurovascular treatment centers regularly perform minimally invasive procedures using neurointerventional devices to manage complex brain conditions. Countries such as Germany, the United Kingdom, and France have strong medical infrastructure and a high number of neurological treatment procedures. The increasing elderly population and rising prevalence of stroke are also supporting steady demand across the region.

Latin America: Latin America is experiencing moderate growth in the neurointerventional device market as healthcare services continue to develop across the region. Countries including Brazil, Mexico, and Argentina are investing in hospital infrastructure and advanced medical technologies to improve neurological treatment capabilities. Increasing awareness regarding stroke treatment and the gradual adoption of minimally invasive procedures are supporting demand for neurointerventional devices. Growth in private healthcare facilities is also contributing to market expansion.

Middle East & Africa: The Middle East & Africa region is witnessing gradual growth in the neurointerventional device market as healthcare infrastructure improves in several countries. Nations such as the UAE, Saudi Arabia, and South Africa are expanding hospital networks and strengthening specialized medical services. Increasing healthcare awareness, improving diagnostic capabilities, and government initiatives aimed at strengthening neurological care are contributing to demand for neurointerventional devices across the region.

Key Players

• The competitive environment is remaining brand-driven, with established players leveraging distribution scale, product breadth, and brand trust. Competitive differentiation is shifting toward material transparency, comfort-led design, and sustainability positioning, while portfolio consolidation and brand acquisition activity are reshaping ownership dynamics.
• Key Players Operating in the Global Neurointerventional Device Market
• Stryker Corporation
• Medtronic plc
• Johnson & Johnson
• Penumbra, Inc.
• Terumo Corporation
• Balt USA LLC
• Merit Medical Systems, Inc.
• Abbott Laboratories
• Boston Scientific Corporation
• Phenox GmbH
• Market Outlook and Strategic Implications
• Growth momentum is remaining stable, while strategic focus is increasingly prioritizing compliance readiness, premiumization, and consumer trust reinforcement. Investment allocation is shifting toward scalable innovation and lifecycle value, as transparency, safety assurance, and access expansion are emerging as long-term competitive differentiators.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 MARKET DEFINITION
• 1.2 MARKET SEGMENTATION
• 1.3 RESEARCH TIMELINES
• 1.4 ASSUMPTIONS
• 1.5 LIMITATIONS

2 RESEARCH METHODOLOGY

• 2.1 DATA MINING
• 2.2 SECONDARY RESEARCH
• 2.3 PRIMARY RESEARCH
• 2.4 SUBJECT MATTER EXPERT ADVICE
• 2.5 QUALITY CHECK
• 2.6 FINAL REVIEW
• 2.7 DATA TRIANGULATION
• 2.8 BOTTOM-UP APPROACH
• 2.9 TOP-DOWN APPROACH
• 2.10 RESEARCH FLOW
• 2.11 DATA AGE GROUPS

3 EXECUTIVE SUMMARY

• 3.1 GLOBAL NEUROINTERVENTIONAL DEVICE MARKET OVERVIEW
• 3.2 GLOBAL NEUROINTERVENTIONAL DEVICE MARKET ESTIMATES AND FORECAST (USD BILLION)
• 3.3 GLOBAL NEUROINTERVENTIONAL DEVICE MARKET ECOLOGY MAPPING
• 3.4 COMPETITIVE ANALYSIS: FUNNEL DIAGRAM
• 3.5 GLOBAL NEUROINTERVENTIONAL DEVICE MARKET ABSOLUTE MARKET OPPORTUNITY
• 3.6 GLOBAL NEUROINTERVENTIONAL DEVICE MARKET ATTRACTIVENESS ANALYSIS, BY REGION
• 3.7 GLOBAL NEUROINTERVENTIONAL DEVICE MARKET ATTRACTIVENESS ANALYSIS, BY PRODUCT TYPE
• 3.8 GLOBAL NEUROINTERVENTIONAL DEVICE MARKET ATTRACTIVENESS ANALYSIS, BY APPLICATION
• 3.9 GLOBAL NEUROINTERVENTIONAL DEVICE MARKET ATTRACTIVENESS ANALYSIS, BY END USER
• 3.10 GLOBAL NEUROINTERVENTIONAL DEVICE MARKET GEOGRAPHICAL ANALYSIS (CAGR %)
• 3.11 GLOBAL NEUROINTERVENTIONAL DEVICE MARKET , BY PRODUCT TYPE (USD BILLION)
• 3.12 GLOBAL NEUROINTERVENTIONAL DEVICE MARKET , BY APPLICATION (USD BILLION)
• 3.13 GLOBAL NEUROINTERVENTIONAL DEVICE MARKET , BY END USER (USD BILLION)
• 3.14 GLOBAL NEUROINTERVENTIONAL DEVICE MARKET , BY GEOGRAPHY (USD BILLION)
• 3.15 FUTURE MARKET OPPORTUNITIES

4 MARKET OUTLOOK

• 4.1 GLOBAL NEUROINTERVENTIONAL DEVICE MARKET EVOLUTION
• 4.2 GLOBAL NEUROINTERVENTIONAL DEVICE MARKET OUTLOOK
• 4.3 MARKET DRIVERS
• 4.4 MARKET RESTRAINTS
• 4.5 MARKET TRENDS
• 4.6 MARKET OPPORTUNITY
• 4.7 PORTER'S FIVE FORCES ANALYSIS
  • 4.7.1 THREAT OF NEW ENTRANTS
  • 4.7.2 BARGAINING POWER OF SUPPLIERS
  • 4.7.3 BARGAINING POWER OF BUYERS
  • 4.7.4 THREAT OF SUBSTITUTE GENDERS
  • 4.7.5 COMPETITIVE RIVALRY OF EXISTING COMPETITORS
• 4.8 VALUE CHAIN ANALYSIS
• 4.9 PRICING ANALYSIS
• 4.10 MACROECONOMIC ANALYSIS

5 MARKET, BY PRODUCT TYPE

• 5.1 OVERVIEW
• 5.2 GLOBAL NEUROINTERVENTIONAL DEVICE MARKET : BASIS POINT SHARE (BPS) ANALYSIS, BY PRODUCT TYPE
• 5.3 EMBOLIC COILS
• 5.4 NEUROVASCULAR STENTS
• 5.5 NEUROTHROMBECTOMY DEVICES

6 MARKET, BY APPLICATION

• 6.1 OVERVIEW
• 6.2 GLOBAL NEUROINTERVENTIONAL DEVICE MARKET : BASIS POINT SHARE (BPS) ANALYSIS, BY APPLICATION
• 6.3 STROKE
• 6.4 CEREBRAL ANEURYSM
• 6.5 ARTERIOVENOUS MALFORMATIONS

7 MARKET, BY END USER

• 7.1 OVERVIEW
• 7.2 GLOBAL NEUROINTERVENTIONAL DEVICE MARKET : BASIS POINT SHARE (BPS) ANALYSIS, BY END USER
• 7.3 HOSPITALS
• 7.4 AMBULATORY SURGICAL CENTERS
• 7.5 SPECIALTY CLINICS

8 MARKET, BY GEOGRAPHY

• 8.1 OVERVIEW
• 8.2 NORTH AMERICA
  • 8.2.1 U.S.
  • 8.2.2 CANADA
  • 8.2.3 MEXICO
• 8.3 EUROPE
  • 8.3.1 GERMANY
  • 8.3.2 U.K.
  • 8.3.3 FRANCE
  • 8.3.4 ITALY
  • 8.3.5 SPAIN
  • 8.3.6 REST OF EUROPE
• 8.4 ASIA PACIFIC
  • 8.4.1 CHINA
  • 8.4.2 JAPAN
  • 8.4.3 INDIA
  • 8.4.4 REST OF ASIA PACIFIC
• 8.5 LATIN AMERICA
  • 8.5.1 BRAZIL
  • 8.5.2 ARGENTINA
  • 8.5.3 REST OF LATIN AMERICA
• 8.6 MIDDLE EAST AND AFRICA
  • 8.6.1 UAE
  • 8.6.2 SAUDI ARABIA
  • 8.6.3 SOUTH AFRICA
  • 8.6.4 REST OF MIDDLE EAST AND AFRICA

9 COMPETITIVE LANDSCAPE

• 9.1 OVERVIEW
• 9.2 KEY DEVELOPMENT STRATEGIES
• 9.3 COMPANY REGIONAL FOOTPRINT
• 9.4 ACE MATRIX
  • 9.4.1 ACTIVE
  • 9.4.2 CUTTING EDGE
  • 9.4.3 EMERGING
  • 9.4.4 INNOVATORS

10 COMPANY PROFILES

• 10.1 OVERVIEW
• 10.2 STRYKER CORPORATION
• 10.3 MEDTRONIC PLC
• 10.4 JOHNSON & JOHNSON
• 10.5 PENUMBRA, INC.
• 10.6 TERUMO CORPORATION
• 10.7 BALT USA LLC
• 10.8 MERIT MEDICAL SYSTEMS, INC.
• 10.9 ABBOTT LABORATORIES
• 10.10 BOSTON SCIENTIFIC CORPORATION
• 10.11 PHENOX GMBH